Novartis Institute For Tropical Diseases Could Have TB Drug In Clinic By Late 2007

The Novartis Institute For Tropical Diseases is developing new drugs for tuberculosis, dengue fever and malaria with the goal of moving a candidate into the clinic for TB as soon as year-end, Novartis' Head of Corporate Research Paul Herrling told "The Pink Sheet" DAILY in a recent interview